Amisulpride is under clinical development by Acacia Pharma and currently in Phase III for Chemotherapy Induced Nausea and Vomiting.

Aviation developments are expected to come in thick and fast in the year ahead, with more options than ever before offered to ...

Ralinepag XR is under clinical development by United Therapeutics and currently in Phase III for Pulmonary Arterial Hypertension.

APD has also made a budget proposal for the ... provide more oversight for newly licensed providers to ensure residents needs are met and required safety protocols to protect people are being ...

SouthState Bank (NYSE: SSB) closed on the $2 billion acquisition of Independent Bank (Nasdaq: IBCP) on Jan. 2. The deal, ...

The Oregon Department of Human Services (ODHS) hired consultant Alvarez and Marsal (A&M) to conduct an independent, external ...

The PsyPal study represents a historic milestone in psilocybin therapy. It was initiated by a multidisciplinary pan-European consortium comprising clinical sites, universities, companies, and ...

Avextra was selected as exclusive provider of the study drug by the consortium earlier ... also known as MND), and atypical Parkinson’s disease (APD). The study will also explore patient access models ...

Mobile and broadband providers have historically increased their ... Air Passenger Duty (APD) will be increased from April 1 2025, meaning flight cost increases for all. APD is a tax on flights ...

The D. E. Shaw group ("D. E. Shaw"), a global investment and technology development firm with more than $65 billion in investment capital and a history of working with companies to help build ...